These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30035835)

  • 1. Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs.
    Grebely J; Larney S; Peacock A; Colledge S; Leung J; Hickman M; Vickerman P; Blach S; Cunningham EB; Dumchev K; Lynskey M; Stone J; Trickey A; Razavi H; Mattick RP; Farrell M; Dore GJ; Degenhardt L
    Addiction; 2019 Jan; 114(1):150-166. PubMed ID: 30035835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
    Degenhardt L; Peacock A; Colledge S; Leung J; Grebely J; Vickerman P; Stone J; Cunningham EB; Trickey A; Dumchev K; Lynskey M; Griffiths P; Mattick RP; Hickman M; Larney S
    Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
    Degenhardt L; Webb P; Colledge-Frisby S; Ireland J; Wheeler A; Ottaviano S; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Grebely J
    Lancet Glob Health; 2023 May; 11(5):e659-e672. PubMed ID: 36996857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis.
    Hines LA; Trickey A; Leung J; Larney S; Peacock A; Degenhardt L; Colledge S; Hickman M; Grebely J; Cunningham EB; Stone J; Dumchev K; Griffiths P; Vickerman P; Mattick RP; Lynskey M
    Lancet Glob Health; 2020 Jan; 8(1):e76-e91. PubMed ID: 31839143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
    Nelson PK; Mathers BM; Cowie B; Hagan H; Des Jarlais D; Horyniak D; Degenhardt L
    Lancet; 2011 Aug; 378(9791):571-83. PubMed ID: 21802134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study.
    Dugan E; Blach S; Biondi M; Cai Z; DePaola M; Estes C; Feld J; Gamkrelidze I; Kottilil S; Ma S; Mathur P; Montoya S; Razavi-Shearer D; Razavi-Shearer K; Robbins-Scott S; Schmelzer J; Razavi H
    Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):169-184. PubMed ID: 33515496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.
    Degenhardt L; Charlson F; Stanaway J; Larney S; Alexander LT; Hickman M; Cowie B; Hall WD; Strang J; Whiteford H; Vos T
    Lancet Infect Dis; 2016 Dec; 16(12):1385-1398. PubMed ID: 27665254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global overview of injecting drug use and HIV infection among injecting drug users.
    Aceijas C; Stimson GV; Hickman M; Rhodes T;
    AIDS; 2004 Nov; 18(17):2295-303. PubMed ID: 15577542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of injecting among people who inject drugs: A systematic review and meta-analysis.
    Colledge S; Leung J; Larney S; Peacock A; Grebely J; Hickman M; Cunningham E; Trickey A; Stone J; Vickerman P; Degenhardt L
    Int J Drug Policy; 2020 Feb; 76():102619. PubMed ID: 31864107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.
    Mohd Hanafiah K; Groeger J; Flaxman AD; Wiersma ST
    Hepatology; 2013 Apr; 57(4):1333-42. PubMed ID: 23172780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global estimates of prevalence of HCV infection among injecting drug users.
    Aceijas C; Rhodes T
    Int J Drug Policy; 2007 Oct; 18(5):352-8. PubMed ID: 17854722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review.
    Hajarizadeh B; Kairouz A; Ottaviano S; Ireland J; Willing A; Cunningham E; Webb P; Colledge-Frisby S; Wheeler A; Leung J; Tran LT; Price O; Vickerman P; Farrell M; Hickman M; Dore GJ; Bergenström A; Degenhardt L; Grebely J
    Lancet Glob Health; 2023 Dec; 11(12):e1885-e1898. PubMed ID: 37973339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access to hepatitis C treatment for people who inject drugs in low and middle income settings: Evidence from 5 countries in Eastern Europe and Asia.
    Luhmann N; Champagnat J; Golovin S; Maistat L; Agustian E; Inaridze I; Myint WM; Butsashvili M; Bouscaillou J
    Int J Drug Policy; 2015 Nov; 26(11):1081-7. PubMed ID: 26342273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.
    Polaris Observatory HCV Collaborators
    Lancet Gastroenterol Hepatol; 2022 May; 7(5):396-415. PubMed ID: 35180382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.
    Stone J; Fraser H; Lim AG; Walker JG; Ward Z; MacGregor L; Trickey A; Abbott S; Strathdee SA; Abramovitz D; Maher L; Iversen J; Bruneau J; Zang G; Garfein RS; Yen YF; Azim T; Mehta SH; Milloy MJ; Hellard ME; Sacks-Davis R; Dietze PM; Aitken C; Aladashvili M; Tsertsvadze T; Mravčík V; Alary M; Roy E; Smyrnov P; Sazonova Y; Young AM; Havens JR; Hope VD; Desai M; Heinsbroek E; Hutchinson SJ; Palmateer NE; McAuley A; Platt L; Martin NK; Altice FL; Hickman M; Vickerman P
    Lancet Infect Dis; 2018 Dec; 18(12):1397-1409. PubMed ID: 30385157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.
    Mahmud S; Mumtaz GR; Chemaitelly H; Al Kanaani Z; Kouyoumjian SP; Hermez JG; Abu-Raddad LJ
    Addiction; 2020 Jul; 115(7):1244-1262. PubMed ID: 32009283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.
    Bao Y; Larney S; Peacock A; Colledge S; Grebely J; Hickman M; Degenhardt L; Leung J
    Int J Drug Policy; 2019 Aug; 70():87-93. PubMed ID: 31125802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of Novel Psychoactive Substance injecting associated with rapid rise in the population prevalence of hepatitis C virus.
    McAuley A; Yeung A; Taylor A; Hutchinson SJ; Goldberg DJ; Munro A
    Int J Drug Policy; 2019 Apr; 66():30-37. PubMed ID: 30690222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.
    Ruta S; Cernescu C
    World J Gastroenterol; 2015 Oct; 21(38):10811-23. PubMed ID: 26478672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence and burden of hepatitis C virus infection in WHO South-East Asia Region: A systematic review.
    Goel A; Rewari BB; Sharma M; Konath NM; Aggarwal R
    J Gastroenterol Hepatol; 2022 Jun; 37(6):964-972. PubMed ID: 35263807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.